Leukemic B cells from chronic lymphocytic leukemia (CLL) patients circulate between peripheral blood and lymphoid tissues where they survive, become activated, and proliferate in close contact with activated T cells, myeloid cells and by receiving signals through the B-cell receptor (BCR). Here, BCR is linked to B-cell chronic lymphocytic leukemia.